| Literature DB >> 33512449 |
Jahnavi Aluri1, Alicia Bach2, Saara Kaviany3, Luana Chiquetto Paracatu2, Maleewan Kitcharoensakkul1,4, Magdalena A Walkiewicz5, Christopher D Putnam6,7, Marwan Shinawi8, Nermina Saucier1, Elise M Rizzi9, Michael T Harmon1, Molly P Keppel1, Michelle Ritter1, Morgan Similuk5, Elaine Kulm10, Michael Joyce11, Adriana A de Jesus12, Raphaela Goldbach-Mansky12, Yi-Shan Lee13, Marina Cella14, Peggy L Kendall9,14, Mary C Dinauer2, Jeffrey J Bednarski2, Christina Bemrich-Stolz15, Scott W Canna16, Shirley M Abraham17, Matthew M Demczko18, Jonathan Powell19, Stacie M Jones20, Amy M Scurlock20, Suk See De Ravin21, Jack J Bleesing22, James A Connelly3, V Koneti Rao21, Laura G Schuettpelz2, Megan A Cooper1.
Abstract
Inborn errors of immunity (IEI) are a genetically heterogeneous group of disorders with a broad clinical spectrum. Identification of molecular and functional bases of these disorders is important for diagnosis, treatment, and an understanding of the human immune response. We identified 6 unrelated males with neutropenia, infections, lymphoproliferation, humoral immune defects, and in some cases bone marrow failure associated with 3 different variants in the X-linked gene TLR8, encoding the endosomal Toll-like receptor 8 (TLR8). Interestingly, 5 patients had somatic variants in TLR8 with <30% mosaicism, suggesting a dominant mechanism responsible for the clinical phenotype. Mosaicism was also detected in skin-derived fibroblasts in 3 patients, demonstrating that mutations were not limited to the hematopoietic compartment. All patients had refractory chronic neutropenia, and 3 patients underwent allogeneic hematopoietic cell transplantation. All variants conferred gain of function to TLR8 protein, and immune phenotyping demonstrated a proinflammatory phenotype with activated T cells and elevated serum cytokines associated with impaired B-cell maturation. Differentiation of myeloid cells from patient-derived induced pluripotent stem cells demonstrated increased responsiveness to TLR8. Together, these findings demonstrate that gain-of-function variants in TLR8 lead to a novel childhood-onset IEI with lymphoproliferation, neutropenia, infectious susceptibility, B- and T-cell defects, and in some cases, bone marrow failure. Somatic mosaicism is a prominent molecular mechanism of this new disease.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33512449 PMCID: PMC8109013 DOI: 10.1182/blood.2020009620
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 25.476